News IMC are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.
Allrights reserved ©2024, Powered by Smart TechOne
Brightcove Inc. (BCOV) stock falls in the pre-market trading. What has happened?
Brightcove Inc. (NASDAQ: BCOV) stock plunged by 0.15% at last close while the BCOV stock keeps on declining by 13.37% in the pre-market trading session after Brightcove has announced its financial results for the first quarter of 2021. Brightcove’s award-winning technology has been helping consumers explore and experience the amazing power of video since 2004, enabling organizations in more than 70 countries around the world to reach audiences in bold and creative ways.
Financial Highlights
On April 28, 2021, BCOV reported its financial results for the first quarter ended March 31, 2021. Given below are the highlights:
Future Outlook
Giving an idea about BCOV’s future business progress, the revenue for the second quarter of 2021 is estimated to be in the range of $49.5 million to $50.5 million, including about $2.7 million in professional services revenue, while revenue for the year is expected to be in the range of $211.0 million to $217.0 million, including about $12.5 million in professional services revenue.
Non-GAAP income from operations is estimated to be between $1.0 million to $2.0 million in Q2 2021, except $9.2 million in stock-based compensation, $3.0 million in amortization of acquired intangible assets, and ($2.0) million in other (benefit) cost. Non-GAAP income from operations is forecast to be in the range of $20.0 million to $25.0 million for the full year 2021.
Most Popular
Artelo Biosciences (ARTL) Stock Soars After Positive Preclinical Results
Aeluma (ALMU) Sees Surge After Being Added to Russell 3000 Index
Skye Bioscience (SKYE) Stock Climbs Sharply Following Promising Drug Presentation
Citius Oncology (CTOR) Advances Commercial Shift With A Launch Update
Related Posts
Artelo Biosciences (ARTL) Stock Soars After Positive Preclinical Results
Aeluma (ALMU) Sees Surge After Being Added to Russell 3000 Index
Skye Bioscience (SKYE) Stock Climbs Sharply Following Promising Drug Presentation
Citius Oncology (CTOR) Advances Commercial Shift With A Launch Update